Nurix Therapeutics Inc
(NRIX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
(Values in U.S. thousands)
| 11-2025 | 08-2025 | 05-2025 | 02-2025 | 11-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -264,457 | -186,236 | -99,815 | -56,351 | -193,569 |
| Depreciation Amortization | 8,534 | 14,225 | 9,225 | 4,128 | 5,140 |
| Accounts receivable | N/A | N/A | -19,000 | N/A | N/A |
| Accounts payable and accrued liabilities | -630 | -3,655 | -5,888 | -3,209 | 5,209 |
| Other Working Capital | -31,596 | -30,046 | -46,507 | -14,029 | -18,401 |
| Other Operating Activity | 38,684 | 24,079 | 37,737 | 8,374 | 29,037 |
| Operating Cash Flow | $-249,465 | $-181,633 | $-124,248 | $-61,087 | $-172,584 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,002 | -8,871 | -6,160 | -3,485 | -9,273 |
| Purchase Of Investment | -455,688 | -281,350 | -178,351 | -110,183 | -707,953 |
| Sale Of Investment | 617,543 | 437,728 | 281,543 | 139,201 | 459,513 |
| Investing Cash Flow | $147,853 | $147,507 | $97,032 | $25,533 | $-257,713 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 3,880 | 2,634 | 1,479 | 1,473 | 296,950 |
| Common Stock Repurchased | N/A | 0 | N/A | N/A | -15 |
| Other Financing Activity | 234,762 | 0 | 0 | 0 | 188,732 |
| Financing Cash Flow | $238,642 | $2,634 | $1,479 | $1,473 | $485,667 |
| Beginning Cash Position | 110,898 | 110,898 | 110,898 | 110,898 | 55,528 |
| End Cash Position | 247,928 | 79,406 | 85,161 | 76,817 | 110,898 |
| Net Cash Flow | $137,030 | $-31,492 | $-25,737 | $-34,081 | $55,370 |
| Free Cash Flow | |||||
| Operating Cash Flow | -249,465 | -181,633 | -124,248 | -61,087 | -172,584 |
| Capital Expenditure | -14,002 | -8,871 | -6,160 | -3,485 | -9,273 |
| Free Cash Flow | -263,467 | -190,504 | -130,408 | -64,572 | -181,857 |